Informed consent for tirzepatide (Mounjaro®) treatment Template

Key Takeaways

Comprehensive risk documentation protects clinic and patient liability

Address branded vs. compounded tirzepatide distinctions explicitly

Digital consent capture ensures audit-ready compliance and secure storage

Understanding Tirzepatide Consent Forms

A tirzepatide consent form is an essential legal and clinical document ensuring patients receive transparent information before starting tirzepatide (Mounjaro®) for weight management or metabolic health. Weight loss and medical spa clinics rely on these forms to document patient understanding of benefits and risks, protecting both practice and patient while establishing clear communication about treatment expectations.

Download Your Free Tirzepatide Informed Consent Form

What is a Tirzepatide Consent Form?

A tirzepatide consent form documents that patients understand the medication’s mechanism, benefits, and potential side effects before starting treatment. Mounjaro® (tirzepatide) is an FDA-approved GLP-1 and GIP receptor agonist for chronic weight management. It regulates appetite and glucose metabolism, making it effective for metabolic health but carrying distinct clinical risks: gastrointestinal effects, pancreatitis, hypoglycemia, and a black box warning regarding medullary thyroid carcinoma.

State medical boards require documented informed consent before prescribing tirzepatide. A properly executed consent form creates a legal record that your clinic disclosed material risks, protecting your practice liability insurance and satisfying HIPAA documentation requirements.

How to Use the Tirzepatide Consent Form

This template integrates into your clinical workflow through five key steps.

1. Present at consultation. Introduce the form at the patient’s initial consultation, before any clinical assessment. Allow time for reading and questions about mechanism, injection schedule, and expected results.
2. Review risks and contraindications. Walk through gastrointestinal effects, injection site reactions, hypoglycemia, pancreatitis, and the medullary thyroid carcinoma warning. Confirm absence of absolute contraindications (thyroid cancer, severe pancreatitis history) and document relative contraindications.
3. Confirm monitoring protocols. Ensure the patient acknowledges thyroid testing (TSH), glucose monitoring if diabetic, and scheduled follow-ups at 2, 4, and 8 weeks post-initiation. Clarify your clinic’s dose escalation and emergency protocols.
4. Obtain witnessed signature. Have the patient sign and date in front of a clinical staff member or provider. The witness must also sign and date, creating an authenticated record. Scan immediately into your digital forms system.
5. File securely and link to records. Upload scanned consent into your EMR and tag with treatment date. If using AI-powered clinical documentation, link consent to the treatment episode so all related notes and injection records are organised together for audit readiness.

Automate consent workflows and clinical documentation

Pabau's digital forms and treatment tracking ensure every tirzepatide consent is captured, signed, and stored with audit-ready security.

Book a demo

Who is the Tirzepatide Consent Form Helpful For?

Medical spas, weight loss clinics, and aesthetic practices offering tirzepatide injections need legally compliant consent documentation. Practitioners managing 50-150 tirzepatide patients monthly benefit from weight loss clinic software that streamlines consent collection across locations. IV therapy, functional medicine, and dermatology clinics adding injectable weight management to their service menu similarly require standardised consent processes.

Multi-location clinics and franchises particularly value standardised templates, ensuring consistency across branches and reducing compliance variance in staff training.

Benefits of Using a Tirzepatide Consent Form

Regulatory compliance: State medical boards require documented consent before prescribing. A signed form creates legal evidence of informed decision-making, reducing malpractice liability if a patient later disputes risk disclosure.

Clear communication: Structured disclosure ensures every patient hears the same essential information-side effects, monitoring protocols, and expectations. Patients who understand what to expect tolerate early effects and remain engaged with treatment.

Insurance and audit readiness: Digital consent systems provide immediate documentation for claims review and regulatory inspections, speeding up credentialing and quality assurance processes.

Compounded vs. Branded Tirzepatide

Your consent form must address whether patients receive branded Mounjaro® or compounded tirzepatide. Both contain the same active ingredient but differ in regulatory oversight. Branded Mounjaro® is FDA-approved with extensive clinical trial data. Compounded tirzepatide is prepared by licensed pharmacies and must meet state pharmacy board standards and USP compounding guidelines but lacks branded clinical trial evidence.

Clearly state which formulation the patient receives. If offering both options, document that the patient understands the regulatory and cost differences. Some clinics note that compounded tirzepatide is more cost-accessible; others emphasise that pharmacy standards remain rigorous regardless of sourcing.

Monitoring and Follow-Up Documentation

Tirzepatide requires systematic clinical follow-up. Your consent should outline your monitoring schedule-typically 2 weeks (side effect assessment), 4 weeks (dose tolerance), and 8 weeks (efficacy and safety review). Specify laboratory testing: baseline and periodic TSH (thyroid screening), fasting glucose or HbA1c if diabetic, and liver/kidney function if clinically indicated.

Document that patients agree to these monitoring requirements and understand that treatment may pause if labs or clinical signs warrant it. Automated measurement tracking eliminates manual errors and creates visual progress records patients can review.

Expert Picks

Need to streamline intake and consent? Digital Forms automate tirzepatide consent capture with electronic signatures and HIPAA-compliant storage integrated into patient records.

Looking to automate clinical notes? Echo AI generates structured documentation from voice dictation, connecting consent forms directly to treatment episodes.

Want to track patient progress? Measurements Tracking logs weight, vitals, and symptom reports at each visit, creating audit-ready safety records.

Conclusion

A comprehensive tirzepatide consent form is the foundation of compliant weight management practice. By disclosing risks, confirming contraindication screening, and obtaining witnessed acknowledgment, your clinic protects patients and practitioners while establishing transparent communication. Digital consent systems automate workflows-from delivery to signature capture to secure storage-ensuring no patient bypasses informed consent and creating an unbreakable audit trail of patient safety.

Frequently Asked Questions